Product Information
IMATINIB MESYLATE 100 MG TAB is a generic product labeled by American Health Packaging, priced at $0.8525 per EA under NDC 60687019221. Its NADAC has been published 445 times since Sep 21, 2016.
The Low Outlier badge above means this manufacturer's average price in the Imatinib Mesylate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
American Health PackagingNDC
60687019221
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA078340On Market Since
2/24/2016
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 100 MG TAB has been published 445 times since Sep 21, 2016, and over the history we have for it it has declined 98.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8525 per EA |
|---|---|
| All-time high | $74.5901 (Nov 16, 2016) |
| All-time low | $0.3890 (May 22, 2024) |
| 52-week high | $0.9761 |
| 52-week low | $0.8525 |
| Median price | $3.1369 |
| Average price | $13.8816 |
| Largest weekly change | -82.3% (Oct 17, 2018) |
| Weeks tracked | 445 |
| Tracking since | Sep 21, 2016 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 100 MG TAB, manufactured by American Health Packaging, is $0.8525 per EA (NDC 60687019221), effective Feb 25, 2026.
How has the price of IMATINIB MESYLATE 100 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 100 MG TAB has declined 98.9%. It has been tracked across 445 weekly CMS publications since Sep 21, 2016.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 100 MG TAB?
Since Sep 21, 2016, the NADAC for IMATINIB MESYLATE 100 MG TAB has ranged from a low of $0.3890 (May 22, 2024) to a high of $74.5901 (Nov 16, 2016), with a median of $3.1369 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 100 MG TAB?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IMATINIB MESYLATE 100 MG TAB, is $0.6632 per EA — about 22% below IMATINIB MESYLATE 100 MG TAB.
Who manufactures IMATINIB MESYLATE 100 MG TAB?
IMATINIB MESYLATE 100 MG TAB (NDC 60687019221) is labeled by American Health Packaging, and CMS classifies it as a generic product.
Related Drugs
Same classification